Literature DB >> 697176

Physiologic effects of bronchopulmonary lavage in alveolar proteinosis.

R M Rogers, D C Levin, B A Gray, L W Moseley.   

Abstract

The clinical and physiologic effects of bronchopulmonary lavage of both lungs at separate times in 14 patients with alveolar proteinosis proved by biopsy were followed for 2 to 96 months. Before lavage, all patients had moderate to severe dyspnea on exertion. Twelve had a nonproductive cough, and 2 had a productive cough; both were smokers. Nine had generalized fatigue, and 4 had weight loss. Twelve of 14 had fine inspiratory rales. All of the patients had abnormal chest roentgenograms, and 13 of 14 had an increased lactate dehydrogenase concentration. After lavage, all patients had loss of fatigue and improved exercise tolerance, with most returning to normal activity. Cough cleared in 12 of 14 and remained only in the cigarette smokers. Inspiratory rales cleared completely in most patients (11 of 12) and partially in one. The rales usually returned during exacerbations. Physiologic measurements that changed significantly after bilateral lavage included: vital capacity, total lung capacity, resting room air PO2, exercise PO2, PO2 while breathing 100 per cent O2, and DLCO. Because all measurements were made within 5 days of the second lavage, one must attribute the acute improvement to the removal of proteinaceous material from the alveoli. The long-term effects varied; some patients required annual or semiannual lavages, wherease others remained in remission after lavage for 36 to 96 months. Exacerbations were accompanied by increased dyspnea, reappearance of rales, and deterioration of the gas-exchange parameters noted previously. Repeat lavage reversed the clinical symptoms and physiologic abnormalities in patients who had recurrences.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 697176     DOI: 10.1164/arrd.1978.118.2.255

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  Bronchoalveolar lavage with trypsin in pulmonary alveolar proteinosis.

Authors:  Y Nagasaka; M Takahashi; H Ueshima; Y Tohda; S Nakajima
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

3.  Serum KL-6 in pulmonary alveolar proteinosis: China compared historically with Germany and Japan.

Authors:  Wen-Liang Guo; Zi-Qing Zhou; Lu Chen; Zhu-Quan Su; Chang-Hao Zhong; Yu Chen; Shi-Yue Li
Journal:  J Thorac Dis       Date:  2017-02       Impact factor: 2.895

4.  Pulmonary alveolar proteinosis: prospective clinical experience in 23 patients for 15 years.

Authors:  K Kariman; J A Kylstra; A Spock
Journal:  Lung       Date:  1984       Impact factor: 2.584

Review 5.  Whole lung lavage-technical details, challenges and management of complications.

Authors:  Ahmed Awab; Muhammad S Khan; Houssein A Youness
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

6.  Alveolar proteinosis: diagnosis and treatment over a 10-year period.

Authors:  R M Du Bois; W A McAllister; M A Branthwaite
Journal:  Thorax       Date:  1983-05       Impact factor: 9.139

7.  Alveolar proteinosis in extremis: a critical case treated with whole lung lavage without extracorporeal membrane oxygenation.

Authors:  Wen-Liang Guo; Yu Chen; Nan-Shan Zhong; Zhu-Quan Su; Chang-Hao Zhong; Shi-Yue Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  Hemodynamic changes during whole bronchoalveolar lavage in two cases of pulmonary alveolar proteinosis.

Authors:  M A Aguinaga; P Santos; E Renes; P F Alvaro; J A Lorente; A Maudes; R R Diaz; L Landín; D Liste
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

9.  Alveolar proteinosis lung lavage using partial cardiopulmonary bypass.

Authors:  A P Freedman; A Pelias; R F Johnston; I P Goel; H I Hakki; T Oslick; J P Shinnick
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

Review 10.  Rare lung disease II: pulmonary alveolar proteinosis.

Authors:  Stephen C Juvet; David Hwang; Thomas K Waddell; Gregory P Downey
Journal:  Can Respir J       Date:  2008 May-Jun       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.